Current position:Home >Product >
Piperidine,1,1'-(4,5-dihydro-1,2-diphenyl-1H-imidazole-4,5-diyl)bis-, trans- (9CI)
Piperidine,1,1'-(4,5-dihydro-1,2-diphenyl-1H-imidazole-4,5-diyl)bis-, trans- (9CI)(65033-73-0)
- Name: Piperidine,1,1'-(4,5-dihydro-1,2-diphenyl-1H-imidazole-4,5-diyl)bis-, trans- (9CI)
- Synonyms:NSC 343765
- Molecular Formula:C25H32 N4
- Molecular Weight:388.5484
- CAS Registry Number:65033-73-0
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.65033-73-0 Piperidine,1,1'-(4,5-dihydro-1,2-diphenyl-1H-imidazole-4,5-diyl)bis-, trans- (9CI)
Assay:90%,98% Appearance:detailed see specifications Package:according to the clients requirement Storage:Store in dry, dark and ventilated place. Transportation:by air or by sea Application:Used in Synthesis, Pharmaceuticals and other fields
Min. Order:1Kilogram
Supplier:Dayang Chem (Hangzhou) Co.,Ltd. [
China (Mainland)]
CAS No.65033-73-0 65033-73-0
Assay:99% Appearance:White powder Package:25KGS/Drum Storage:Room temperature Transportation:BY SEA Application:API锛孭harmaceutical intermediates
Min. Order:1Gram
Supplier:HENAN NEW BLUE CHEMICAL CO.,LTD [
China (Mainland)]

Other Product
- 63844-41-7/Spiro[1H-indene-1,4'-[4H]inden]-7-ol,1'-[(1R)-1,5-dimethylhexyl]-1',2',3',3'a,5,5',6,6',7,7',7a,7'a-dodecahydro-4,7'a-dimethyl-,(1R,1'R,3'aR,7S,7aR,7'aR)- (9CI)
- 152615-99-1/Phenol,4,4'-(1-methylethylidene)bis-, polymer with 1,1'-sulfonylbis[4-chlorobenzene],sulfonated
- 30140-39-7/hexane-1,1-diamine
- 94109-30-5/p-[[1-hydroxy-6-[[[[5-hydroxy-7-sulpho-6-[(4-sulpho-o-tolyl)azo]-2-naphthyl]amino]carbonyl]amino]-3-sulpho-2-naphthyl]azo]benzoic acid, sodium salt, compound with 2-aminoethanol
- 159910-86-8/Droxinavir
- 20711-88-0/1,3,5,7,9,11-Hexasilapentacyclo[6.4.0.02,7.04,11.05,10]dodecane(8CI,9CI)
- 169563-63-7/7H-Purine-7-acetic acid, 1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-, 2 -(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)ethyl ester
- 61925-59-5/linear-benzoadenosine diphosphate
- 90390-06-0/N-(3-nitrobenzyl)pentan-1-amine
- 2226-25-7/Benzeneethanamine, b,b'-dithiobis[N,N,a-trimethyl-, [aR*,bR*(a'R*,b'R*)]- (9CI)
- 3264-93-5/1(2H)-Pyridinyloxy,3,6-dihydro-2,2,6,6-tetramethyl-
- 5848-56-6/(3-ethoxypropyl)benzene
- 29571-45-7/methyl (2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)acetate
- 66264-72-0/4-hydroxy-alpha-[[[3-(4-methoxyphenyl)-1-methylpropyl]amino]methyl]-3-(methylthio)benzyl alcohol
- 76561-86-9/(1S,2R,3R,4S)-1,2,3,4-tetrahydronaphthalene-1,2,3,4-tetrol
- 5824-36-2/2,9-Dioxa-3,8-disiladecane
- 126039-09-6/walleminol A
- 113849-24-4/4-(6,8-dibromo-2-methyl-4-oxoquinazolin-3(4H)-yl)-N-(phenylcarbamoyl)benzenesulfonamide
- 144031-03-8/Poly(oxy-1,2-ethanediyl), .alpha.-isodecyl-.omega.-hydroxy-, (2Z)-2-butenedioate
- 65033-73-0/Piperidine,1,1'-(4,5-dihydro-1,2-diphenyl-1H-imidazole-4,5-diyl)bis-, trans- (9CI)
- 6944-24-7/phenyl[2-(pyridin-3-yl)piperidin-1-yl]methanone
- 71326-30-2/N,N-bis(3-aminopropyl)-N',N'-dimethylpropane-1,3-diamine
- 67445-55-0/ethyl 2-nitrophenyl (1-methylethyl)amidophosphate
- 205-10-7/7H-benzo[b]naphtho[1,2-d]borol-7-yl
- 885-98-3/2,5-dimethylbenzene-1,4-diyl diacetate
- 18847-18-2/5-(4-ISO-PROPYLPHENYL)-5-OXOVALERIC ACID
- 142082-79-9/D-Alaninamide,N-[(3S)-1-oxo-3-phenylbutyl]-L-histidyl-L-tryptophyl-L-alanyl-L-valyl-N-[(1S)-2-[(2R)-2-[[[(1S)-2-amino-2-oxo-1-(phenylmethyl)ethyl]amino]methyl]-1-pyrrolidinyl]-1-(1H-imidazol-4-ylmethyl)-2-oxoethyl]-(9CI)
- 113919-27-0/1,2-Benzenediol,4-[3-[4-(acetyloxy)-3-hydroxyphenyl]-1,1-dioxido-3H-2,1-benzoxathiol-3-yl]-(9CI)
- 6814-59-1/17-(prop-2-en-1-yl)morphinan-3-ol 2,3-dihydroxybutanedioate (1:1)
- 23179-61-5/Spiro[2-cyclohexene-1,7'(1'H)-cyclopent[ij]isoquinolin]-4-one,2',3',8',8'a-tetrahydro-6'-hydroxy-5'-methoxy-, (1S,8'aR)-